As therapeutic antibodies evolve, the industry is moving away from a one-size-fits-all chromatography approach. With an increasing share of non-traditional monoclonal antibodies (mAbs)—including ...

Chromatography refuses to be overwhelmed by the processing demands and cost pressures associated with next-generation medicines. Instead, chromatography is strengthening its commitment to innovation.